VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AIRSAirSculpt Technologies, Inc.
$4.57$322M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAIRSBalance Sheet

AirSculpt Technologies, Inc. (AIRS) Balance Sheet

7Y historyFree accessUpdated daily

The company maintains a vulnerable capital structure with a debt-to-equity ratio of 0.71 and a significant goodwill concentration of $81.7 million relative to $192.0 million in total assets.

AIRS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets24.33M15.46M17.12M15.96M16.68M29.44M11.56M6.59M
Cash & Short-Term Investments16.69M8.45M8.23M10.26M9.62M25.35M10.38M5.13M
Cash Only16.69M8.45M8.23M10.26M9.62M25.35M10.38M5.13M
Short-Term Investments00000000
Accounts Receivable1.97M1.5M3.06M1.94M2.83M000
Days Sales Outstanding3.173.66.183.626.12---
Inventory00000000
Days Inventory Outstanding--------
Other Current Assets5.67M5.51M5.83M3.76M4.23M000
Total Non-Current Assets167.67M171.85M192.88M188.06M184.08M171.11M168.05M164.91M
Property, Plant & Equipment47.26M50.27M63.14M54.32M47.97M31.79M24.16M16.48M
Fixed Asset Turnover4.10x3.02x2.86x3.61x3.52x4.19x2.60x2.50x
Goodwill81.73M81.73M81.73M81.73M81.73M81.73M81.73M81.73M
Intangible Assets35.65M36.84M41.59M46.35M51.1M55.85M60.61M65.36M
Long-Term Investments00046.35M-8.43M-5.82M00
Other Non-Current Assets3.02M3.01M6.41M-40.69M3.28M1.74M1.54M1.34M
Total Assets192M187.3M210M204.02M200.76M200.55M179.61M171.5M
Asset Turnover0.80x0.81x0.86x0.96x0.84x0.66x0.35x0.24x
Asset Growth %-32.66%-10.81%2.93%1.62%0.1%11.66%4.73%-
Total Current Liabilities32.48M27.9M28.61M20.32M22.32M16.41M9.46M8.35M
Accounts Payable7.46M5.37M6.26M3.92M3.84M2.67M1.09M2.11M
Days Payables Outstanding31.4431.7631.9919.3424.0721.8817.0349.82
Short-Term Debt12.64M5.46M4.25M2.13M2.13M850K400K400K
Deferred Revenue (Current)6.89M1.87M1.17M1.46M2.36M2.81M3.23M3.19M
Other Current Liabilities5.84M003.3M000174K
Current Ratio0.75x0.55x0.60x0.79x0.75x1.79x1.22x0.79x
Quick Ratio0.75x0.55x0.60x0.79x0.75x1.79x1.22x0.79x
Cash Conversion Cycle-28.27-------
Total Non-Current Liabilities59.26M71.69M102.1M99.71M107.67M100.61M46.48M42.76M
Long-Term Debt39.36M50.59M70.46M69.5M81.42M81.75M32.12M32.31M
Capital Lease Obligations81.93M20.23M24.25M22.66M19.75M14.51M14.36M10.45M
Deferred Tax Liabilities8.33M878K6.58M6.83M5.49M4.35M00
Other Non-Current Liabilities00817K716K1.02M4.35M00
Total Liabilities91.74M99.59M130.71M120.03M129.99M117.03M55.93M51.11M
Total Debt71.02M83.57M105.05M99.67M107.65M100.58M49.77M45.1M
Net Debt54.33M75.12M96.82M89.41M98.03M75.24M39.39M39.97M
Debt / Equity0.71x0.95x1.32x1.19x1.52x1.20x0.40x0.37x
Debt / EBITDA58.11x10.51x10.43x5.05x30.62x4.50x3.18x8.02x
Net Debt / EBITDA44.46x9.45x9.61x4.53x27.88x3.36x2.51x7.11x
Interest Coverage-1.31x-1.90x-0.29x1.46x-0.51x3.23x4.09x0.23x
Total Equity100.26M87.71M79.29M83.99M70.77M83.53M123.68M120.39M
Equity Growth %46.97%10.62%-5.6%18.69%-15.28%-32.46%2.73%-
Book Value per Share1.441.451.371.481.271.502.222.16
Total Shareholders' Equity100.26M87.71M79.29M83.99M70.77M83.53M123.68M120.39M
Common Stock71K64K58K57K56K56K123.68M120.39M
Retained Earnings-42.97M-40.57M-27.8M-19.55M-15.07M-393K00
Treasury Stock00000000
Accumulated OCI-254K-96K-687K-412K-76K000
Minority Interest00000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and Solvency Constraints

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Erosion Amid Contraction

According to recent quarterly filings, AIRS has seen its equity base decline from $84.0 million in 2023Q4 to $87.7 million in 2025Q4, while retained earnings have deepened to a deficit of $40.6 million, signaling a persistent deterioration in the company's fundamental financial health over the observed period.

The consistent expansion of the retained earnings deficit suggests that the company's operational model is failing to generate sufficient returns to offset its accumulated losses. This trajectory indicates that the business is currently consuming its capital base rather than growing it, which warrants significant caution regarding long-term viability.

Leverage Pressures Amid Revenue Declines

Based on reported financial statements, the company's debt-to-equity ratio has fluctuated significantly, peaking at 1.32 in early 2025, which reflects a reliance on external financing to support operations during a period where revenue growth has turned negative and cash generation has become increasingly unreliable.

The high leverage relative to the company's current cash-burning status suggests that debt service obligations may become a critical constraint on future operational flexibility. Investors should monitor whether the company can refinance these obligations without further diluting shareholders or incurring prohibitive interest costs.

Tight Liquidity Limits Operational Runway

As indicated by the latest balance sheet data, the current ratio has remained consistently below 1.0, reaching a low of 0.51 in 2025Q3, which highlights a precarious liquidity position that leaves the firm with minimal buffer against unexpected shocks or further declines in procedure volume.

A current ratio consistently below unity implies that the company may struggle to meet its short-term obligations using only its current assets. This liquidity constraint appears to be a direct consequence of the company's inability to maintain positive cash flow, forcing a reliance on external capital to fund day-to-day operations.

Goodwill Concentration Risks Asset Quality

Analysis of the asset composition reveals that goodwill remains static at $81.7 million, representing a substantial portion of the $187.3 million total assets reported in 2025Q4, which suggests that the balance sheet is heavily reliant on intangible valuations that may be vulnerable to future impairment.

The high concentration of goodwill relative to total assets indicates that the company's book value is sensitive to the performance of its underlying clinical units. Should the current revenue contraction persist, the risk of a significant goodwill write-down increases, which would further erode the company's equity position.

Hidden Risks in Capital Structure

Data from recent filings suggests that the company's reliance on debt to fund its clinical footprint, combined with a negative retained earnings balance, creates a structural vulnerability where any further decline in operating performance could trigger a breach of existing debt covenants or necessitate dilutive equity raises.

The combination of high debt levels and negative operating margins creates a feedback loop that limits the company's ability to pivot its strategy. This structural imbalance suggests that the headline asset figures may overstate the company's true financial strength, as the underlying assets are not currently generating sufficient returns to cover the cost of the capital used to acquire them.

AIRS — Frequently Asked Questions

Quick answers to the most common questions about buying AIRS stock.

What are the total assets of AirSculpt Technologies, Inc. (AIRS)?

As of 2025, AirSculpt Technologies, Inc. (AIRS) had total assets of $187.3M including $15.5M in current assets.

How much debt does AirSculpt Technologies, Inc. (AIRS) have?

AirSculpt Technologies, Inc. (AIRS) carries total debt of $83.6M, offset by $8.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of AirSculpt Technologies, Inc.?

AirSculpt Technologies, Inc. (AIRS) has total shareholders' equity (book value) of $87.7M ($1.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is AirSculpt Technologies, Inc.'s current ratio and liquidity?

AirSculpt Technologies, Inc. (AIRS) reported a current ratio of 0.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.